Transmittals

Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for Solid Tumors

National Coverage Determination (NCD) for Single Chamber and Dual Chamber Permanent Cardiac Pacemakers

Medicare National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease

Addition of New Fields, Expansion of Existing Model 1 Discount Percentage Field in the Inpatient Hospital Provider Specific File (PSF) and Update of Model 4 Bundled Payment of Care Initiative (BPCI) Payment Calculation to Include Uncompensated Care Payment

Addition of New Fields, Expansion of Existing Model 1 Discount Percentage Field in the Inpatient Hospital Provider Specific File (PSF) and Update of Model 4 Bundled Payment of Care Initiative (BPCI) Payment Calculation to Include Uncompensated Care Payment

Therapy Modifier Consistency Edits

Therapy Modifier Consistency Edits

Enforcement of the 5 Day Payment Limit for Respite Care Under the Hospice Medicare Benefit

Enforcement of the 5 Day Payment Limit for Respite Care Under the Hospice Medicare Benefit

Aprepitant for Chemotherapy Induced Emesis

Aprepitant for Chemotherapy Induced Emesis

Aprepitant for Chemotherapy Induced Emesis

Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for Solid Tumors

Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for Solid Tumors

National Coverage Determination (NCD) for Single Chamber and Dual Chamber Permanent Cardiac Pacemakers

National Coverage Determination (NCD) for Single Chamber and Dual Chamber Permanent Cardiac Pacemakers

Medicare National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease

Medicare National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease

Chapter 1, language-only update

Chapter 1, language-only update